MedTrace Logo

Biomarker Study to Evaluate Correlations Between Epigenetic Aging and NAD+ Levels in Healthy Volunteers

NCT04220658 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2023-02-15

No results posted yet for this study

Summary

This is a single center, prospective study to evaluate correlations between epigenetic aging (as measured via DNA methylation) and NAD+ levels in healthy volunteers.

Conditions

  • Epigenetics

Interventions

OTHER

Biomarker study

Biomarkers of aging including NAD+ levels in whole blood, interleukins, inflammatory cytokines, growth factors, omega-3 polyunsaturated fatty acids, and patterns in DNA methylation

Sponsors & Collaborators

  • Duke Clinical Research Institute

    collaborator OTHER

  • Elysium Health

    lead INDUSTRY

Principal Investigators

  • Jeffrey Guptill, MD · Duke Early Phase Clinical Research/DCRI

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-19
Primary Completion
2023-12-01
Completion
2023-12-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04220658 on ClinicalTrials.gov